Ownership history in Lindbrook Capital, LLC · 2 quarters on record
This page tracks every 13F SEC filing in which Lindbrook Capital, LLC reported a position in DIANTHUS THERAPEUTICS INC COM (DNTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | ADDED | 21 | +4 | +23.5% | 0.00% | $458 | $21.80 |
| 2024 Q3 | INITIATED | 17 | — | — | 0.00% | $465 | $27.38 |
As of 2025 Q4 — sorted by position size